Truvada and other antiretroviral drugs containing the active ingredient tenofovir disoproxil fumarate, TDF, increases the risk of bone density loss, fracture, renal impairment, and kidney failure. More than 600,000 Americans take Truvada or other TDF drugs contributing to over 9 million individuals worldwide.
Gilead Sciences – Profits over Safety?
TDF is manufactured and sold by Gilead Sciences, Inc. under several brand names including Vired, Atripla, Complera, Stribild, and Truvada. TDF is a main component of the most commonly prescribed drug, Truvada, an HIV/AIDS medication used to treat HIV, and prevent HIV acquisition in the prevention method known as pre-exposure prophylaxis, or PrEP. Truvada may pose serious side effects that may cause injury and permanent damage including kidney failure, renal impairment, bone density loss, bone fractures, and osteoporosis.
Truvada first became available on the US market in 2001 and grew to dominate the global market for HIV treatment and prevention. A new tenofovir drug called tenofovir alafenamide (TAF) was developed by Gilead shortly after Truvada first became available in the United States around 2001. The newly developed drug proved to be more effective at a lower dose and had a significantly reduced risk for kidney problems when compared to TDF.
Despite early indications that TAF was a safer alternative with lower toxicity, Gilead halted clinical research in 2004 and did not start again until 2010. During this time, millions of individuals worldwide were prescribed Truvada with TDF and were unwittingly exposed to an increased risk for permanent injuries including kidney failure, renal failure, bone density loss, and osteoporosis.
Injuries Related to the use of TDF or Truvada
– Kidney Failure
– Kidney Disease
– Bone Fractures
– Bone Demineralization
– Liver Failure
You may be eligible for compensation if you suffered from any of the above symptoms as a result of taking Truvada. Our Truvada attorneys are currently investigating potential claims for those who have experienced any of the above injuries as a result from taking Truvada.
Call 800-701-3672 to report kidney failure, bone fractures, osteoporosis, or any other side effect that you may have suffered from the use of Truvada.
The kidneys are small organs that contain millions of nephrons, which are made of blood vessels and fluid-collecting tubes. This system of vessels and tubes typically process the body’s entire blood supply 30 to 40 times during a single day and remove two quarts of waste and water each day in the form of urine. TDF, the active ingredient in Truvada, accumulates in the kidney tubules, causing damage to the nephrons and therefore lowering the function of the kidney.
Even though kidney problems are commonly present in people with HIV, Truvada has been found to increase the risk for chronic kidney disease and renal failure compared to the safer, and more effective TAF medications. Common kidney problems associated with the use of Truvada include kidney disease, kidney failure, renal disease, and renal failure.
Call Hollis Law Firm immediately at 1-800-701-3672 to report kidney failure, or any other side effect that you think might be related to the effects of Truvada.
FDA Warnings to Gilead Sciences regarding the dangers of TDF
FDA issues a letter to Gilead Sciences notifying of the increased risk of kidney failure from the use of Truvada. Gilead Sciences states Truvada was not toxic and was not linked to kidney failure, despite the existence of documented kidney failure noted on clinical research and the drug’s warning label.
FDA issues a second letter to Gilead Sciences demanding a clear and precise answer regarding Truvada. Again, Gilead Sciences downplayed the danger of kidney failure and promoted the safe and effective use of the TDF version of Truvada.
June 27, 2014:
FDA issues third warning to Gilead Sciences, highlighting a sponsored web link that promoted Truvada’s safety while failing to mention the risk of kidney failure. Gilead Sciences was required to remove the link.
Additional information regarding Truvada
In a study of 10,000 HIV positive patients, chronic kidney disease rose 33 percent each year from taking Truvada. Additionally, signs of kidney disease remained for at least a year following the conclusion of treatment.
Official FDA records of a Feb 2017 study conducted on the safety and utilization of Truvada.
Additional information for all classes of antiretroviral drugs including: Multi-class combination drugs, Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs), Protease Inhibitors (PIs), Fusion Inhibitors, and Entry Inhibitors.
Call the Hollis Law Firm at 1-800-701-3672 if you or a loved one has taken Truvada and developed kidney failure, bone fractures, osteoporosis, renal failure, or kidney failure. All calls and case evaluations are free and carry no obligation.
TRUVADA, the TRUVADA Logo, TRUVADA for PrEP, the TRUVADA for PrEP Logo, the TRUVADA Blue Pill Design, ADVANCING ACCESS, GILEAD, and the GILEAD Logo are trademarks of Gilead Sciences, Inc., or its related companies.